EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CD8+ T Cell Exhaustion and Tumor Immune Checkpoint Blockade: Mechanisms, Heterogeneity, and Combination Intervention Strategies

Gang Liu

Advances in World Medical Research · 30.09.2026 · 2 (3) · 78-86

DOI: 10.71204/dkzdp879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in World Medical Research, online erschienen am 30.09.2026. Verfasst von Gang Liu. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD8+ T cells are the core effector cells in anti-tumor immunity, but under continuous tumor antigen stimulation and inhibitory microenvironment, they gradually enter a state of dysfunction, showing reduced effector secretion, decreased proliferation, persistent expression of inhibitory receptors, and abnormal metabolic adaptation, which are driven by a unified transcriptional, epigenetic, metabolic, and microenvironmental exhaustion program. T cell exhaustion is a major reason why immune checkpoint blockade (ICB) therapy has limited effectiveness and also a key target for combination treatment strategies. In recent years, single-cell sequencing, spatial transcriptomics, and functional immunology studies have shown that exhausted T cells are not a single state-they include heterogeneous subgroups such as progenitor exhausted T cells (Tpex), intermediate exhausted T cells, and terminal exhausted T cells. Blocking PD-1/PD-L1 and CTLA-4 can partly restore T cell function, but primary and secondary resistance are still common. This article reviews the unified mechanisms of CD8+ T cell exhaustion and, organized around the axis of 'mechanism–heterogeneity–ICB response–combination strategies', explores potential strategies for immune checkpoint blockade related to CD8+ T cell exhaustion, and also discusses biomarkers and future research directions.

Zitieren

APA

Liu, G. (2026). CD8+ T Cell Exhaustion and Tumor Immune Checkpoint Blockade: Mechanisms, Heterogeneity, and Combination Intervention Strategies. Advances in World Medical Research, 2(3), 78-86. https://doi.org/10.71204/dkzdp879

Vancouver

Liu G. CD8+ T Cell Exhaustion and Tumor Immune Checkpoint Blockade: Mechanisms, Heterogeneity, and Combination Intervention Strategies. Advances in World Medical Research. 2026;2(3):78-86. doi:10.71204/dkzdp879

BibTeX
@article{Liu2026,
  author = {Liu, Gang},
  title = {CD8+ T Cell Exhaustion and Tumor Immune Checkpoint Blockade: Mechanisms, Heterogeneity, and Combination Intervention Strategies},
  journal = {Advances in World Medical Research},
  year = {2026},
  volume = {2},
  number = {3},
  pages = {78--86},
  doi = {10.71204/dkzdp879}
}
Kostenlos starten →